Jim Cramer on Thermo Fisher: “Maybe This Stock Can Finally Get its Groove Back”

Core Insights - Thermo Fisher Scientific Inc. reported better than expected earnings with accelerating organic revenue growth, indicating potential recovery after a period of stagnant trading [1] - The company is recognized for supplying laboratory products, analytical instruments, diagnostics, and biopharma services that support scientific research, healthcare, and industrial applications [2] - Comparatively, Danaher is viewed as a stronger investment option than Thermo Fisher, despite both companies facing challenges during the COVID-19 pandemic [2] Financial Performance - The latest earnings report showed a significant top and bottom line beat for Thermo Fisher, suggesting improved financial health [1] - The company has experienced a period of sideways trading for the past few years, but recent results may signal a turnaround [1] Market Position - Thermo Fisher has been impacted by the COVID-19 pandemic, which has affected its stock performance [2] - There is a belief that certain AI stocks may offer greater upside potential compared to Thermo Fisher, indicating a competitive landscape in the investment market [2]